By Dr. John Lewis Like most of us, Dr. John Lewis had different plans for 2020. By the end of 2019, his biotechnology company, Entos Pharmaceuticals, was generating a lot of buzz for its proprietary drug delivery platform. The platform, known as Fusogenix, uses cutting-edge nanotechnology to bring targeted medicines directly to specific cells in […]